Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Danaher Corp DHR

Technology Scientific & Technical Instruments
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the... see more

Recent & Breaking News (NYSE:DHR)

Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies

PR Newswire March 7, 2023

Danaher Announces Quarterly Dividends

PR Newswire February 22, 2023

Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto

PR Newswire February 8, 2023

Danaher Reports Fourth Quarter and Full Year 2022 Results

PR Newswire January 24, 2023

Danaher CEO to Comment on Financial Performance

PR Newswire January 9, 2023

Danaher to Present at J.P. Morgan Healthcare Conference

PR Newswire January 3, 2023

Danaher Schedules Fourth Quarter 2022 Earnings Conference Call

PR Newswire December 27, 2022

Danaher Announces Quarterly Dividends

PR Newswire December 6, 2022

Danaher to Present at Evercore ISI HealthCONx Conference

PR Newswire November 22, 2022

Cepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health Diagnosis in U.S.

PR Newswire November 15, 2022

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

PR Newswire November 10, 2022

Danaher Reports Third Quarter 2022 Results

PR Newswire October 20, 2022

Danaher Releases 2022 Sustainability Report and Announces New Greenhouse Gas Emissions Reduction Target

PR Newswire October 5, 2022

Danaher Schedules Third Quarter 2022 Earnings Conference Call

PR Newswire September 20, 2022

Danaher CEO to Comment on Financial Performance

PR Newswire September 14, 2022

Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company

PR Newswire September 14, 2022

Danaher Announces Quarterly Dividends

PR Newswire September 13, 2022

Danaher to Webcast Bioprocessing Investor and Analyst Meeting at Cytiva

PR Newswire September 1, 2022

Beckman Coulter Partners with Mass General and BARDA to Identify Severe Pediatric Infections in Emergency Departments

PR Newswire July 25, 2022

Danaher Reports Second Quarter 2022 Results

PR Newswire July 21, 2022